Page last updated: 2024-12-06

quinuclidinyl benzilate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID23056
CHEMBL ID12980
SCHEMBL ID59698
MeSH IDM0018360
PubMed CID688566
CHEMBL ID558910
SCHEMBL ID241173
MeSH IDM0018360

Synonyms (107)

Synonym
[3h]quinuclidinylbenzilate
gtpl318
[3h]qnb
nsc168347
nsc173698
nsc-168347
6581-06-2
benzeneacetic acid, 1-azabicyclo[2.2.2]oct-3-yl ester
ro 2-3308
NSC170423 ,
3-quinuclidinyl benzilate
bz
L001186
CHEMBL12980 ,
1-azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate
bdbm50010096
hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester(qnb)
hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester
hydroxy-diphenyl-acetic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester(r)-(-)-(qnb)
(+-)-oxyquinuclidine benzilate
benzilic acid, 3-quinuclidinyl ester, (+-)-
(+-)-ro 2-3308
niosh/dd4639000
(+-)-beta-quinuclidinyl benzilate
(+-)-3-quinuclidyl benzilate
(+-)-3-hydroxyquinuclidine benzilate
(+-)-3-quinuclidinol benzilate
DD46390000 ,
benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester, (+-)-
(+-)-3-quinuclidinyl benzilate
benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester
benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester
substance 78
gtpl3260
3-quinuclidinyl-benzilate
1-azabicyclo[2.2.2]octan-8-yl 2-hydroxy-2,2-di(phenyl)acetate
ea-2277
SCHEMBL59698
r-(-)-3-quinuclidinyl benzilate
HGMITUYOCPPQLE-UHFFFAOYSA-N
1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate #
(+/-)-quinuclidinyl benzilate
(+/-)-quinuclidinyl benzilate, powder
AKOS027321160
quinuclidin-3-yl 2-hydroxy-2,2-diphenyl-acetate
3-quinuclidinylbenzilate
NCGC00485298-01
Q223068
DTXSID00894168
benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester
r(-)-quinuclidinyl benzilate
nsc-173698
qnb ,
3-quinuclidyl benzilate
benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester
3-quinuclidinol benzilate
benzilic acid, 3-quinuclidinyl ester
bz [anticholinergic]
3-(2,2-diphenyl-2-hydroxyethanoyloxy)-quinuclidine
1-azabicyclo(2.2.2)octan-3-ol, benzilate
nsc 173698
3-chinuclidylbenzilate
ea 2277
cs 4030
(r)-(-)-3-quinuclidinyl benzilate
CHEMBL558910 ,
[(3r)-1-azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-diphenylacetate
(3r)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate
unii-vf416m2d3p
(r)-quinuclidinyl benzilate
vf416m2d3p ,
quinuclidinyl benzilate, (-)-
benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester, (-)-
62869-69-6
(-)-quinuclidinyl benzilate
e69dlr7470 ,
agent bz
agent buzz
hsdb 7533
buzz
unii-e69dlr7470
(r)-(-)-qnb
(r)-3-quinuclidinyl benzilate
(r)-quinuclidin-3-yl 2-hydroxy-2,2-diphenylacetate
quinuclidinyl benzilate, (r)-
(-)-3-quinuclidinyl benzilate
(r)-qnb
benzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, (3r)-1-azabicyclo(2.2.2)oct-3-yl ester
3-quinuclidinol dl-form benzilate (ester) [mi]
quinuclidinyl benzilate, (+/-)-
ro-2-3308
3-oxyquinuclidine benzilate
3-quinuclidinol, benzilate (ester)
2,2-diphenyl-2-hydroxyacetic acid 3-quinuclidinyl ester
.beta.-quinuclidinyl benzilate
3-hydroxyquinuclidine benzilate
SCHEMBL241173
hydroxy-diphenyl-acetic acid (r)-(1-aza-bicyclo [2.2.2]oct-3-yl) ester
hydroxyl-diphenyl-acetic acid(r)-(1-aza-bicyclo-[2.2.2]oct-3-yl)ester
hydroxydiphenyl-acetic acid (r)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester
HGMITUYOCPPQLE-IBGZPJMESA-N
hydroxy-diphenyl-acetic acid (r)-(1-aza-bicyclo[2.2.2]oct-3-yl) ester
hydroxy-diphenyl-acetic acid (r)-(1-aza-bicyclo[2.2.2]oct-3-yl)ester
hydroxy-diphenyl-acetic acid (r)-(1-aza-bicyclo [2.2.2]oct-3-yl)ester
bdbm50450592
Q27464767
FT-0773200

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (13)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Muscarinic acetylcholine receptor M2Homo sapiens (human)Ki0.00010.00000.690210.0000AID141150; AID141151; AID141152; AID141156; AID142111
Muscarinic acetylcholine receptor M4Homo sapiens (human)Ki0.00020.00000.79519.1201AID141150; AID141151; AID141152; AID141156
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Ki0.00020.00010.579710.0000AID141077
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)Ki0.00020.00011.48339.1400AID141077
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)Ki0.00020.00010.68688.2600AID141077
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)Ki0.00020.00010.66618.2600AID141077
Muscarinic acetylcholine receptor M5Homo sapiens (human)Ki0.00020.00000.72926.9183AID141150; AID141151; AID141152; AID141156
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.00020.00010.58908.2600AID141077
Muscarinic acetylcholine receptor M1Homo sapiens (human)Ki0.00020.00000.59729.1201AID141150; AID141151; AID141152; AID141156
Muscarinic acetylcholine receptor DM1Drosophila melanogaster (fruit fly)Ki0.00050.00051.42495.2000AID1090601; AID1090602
Muscarinic acetylcholine receptor M3Homo sapiens (human)Ki0.00020.00000.54057.7600AID141150; AID141151; AID141152; AID141156
Vesicular acetylcholine transporterRattus norvegicus (Norway rat)Ki0.58170.00130.56224.5230AID674902
Muscarinic acetylcholine receptorCavia porcellus (domestic guinea pig)Ki0.00020.00010.61203.8019AID141077
Muscarinic acetylcholine receptor M2Homo sapiens (human)IC50 (µMol)0.00040.00001.23267.7930AID430617
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.00220.00010.58908.2600AID34453
Muscarinic acetylcholine receptor M1Homo sapiens (human)IC50 (µMol)0.00040.00001.403910.0000AID430616
Muscarinic acetylcholine receptor M3Homo sapiens (human)IC50 (µMol)0.00090.00011.01049.9280AID430618
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Kd0.00030.00031.85009.1000AID141695
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Kd0.00020.00021.38829.1000AID142932
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (39)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of heart contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
response to virusMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M2Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M4Homo sapiens (human)
cell surface receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M4Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M4Homo sapiens (human)
gastric acid secretionMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
dopamine transportMuscarinic acetylcholine receptor M5Homo sapiens (human)
transmission of nerve impulseMuscarinic acetylcholine receptor M5Homo sapiens (human)
regulation of phosphatidylinositol dephosphorylationMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M5Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M5Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
positive regulation of monoatomic ion transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
neuromuscular synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M1Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M1Homo sapiens (human)
cognitionMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of postsynaptic membrane potentialMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of glial cell proliferationMuscarinic acetylcholine receptor M1Homo sapiens (human)
positive regulation of intracellular protein transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
calcium-mediated signalingMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of monoatomic ion transmembrane transporter activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
synaptic transmission, cholinergicMuscarinic acetylcholine receptor M3Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of insulin secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein modification processMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ligand-gated ion channel signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of heart contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
response to virusMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M2Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
positive regulation of monoatomic ion transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
neuromuscular synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M1Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M1Homo sapiens (human)
cognitionMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of postsynaptic membrane potentialMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of glial cell proliferationMuscarinic acetylcholine receptor M1Homo sapiens (human)
positive regulation of intracellular protein transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
calcium-mediated signalingMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of monoatomic ion transmembrane transporter activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
synaptic transmission, cholinergicMuscarinic acetylcholine receptor M3Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of insulin secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein modification processMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ligand-gated ion channel signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
arrestin family protein bindingMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
signaling receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
arrestin family protein bindingMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
signaling receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
clathrin-coated endocytic vesicle membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
asymmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
symmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
neuronal cell bodyMuscarinic acetylcholine receptor M2Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M2Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M4Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M4Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M5Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M5Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M1Homo sapiens (human)
Schaffer collateral - CA1 synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic density membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M1Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
endoplasmic reticulum membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basal plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basolateral plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
clathrin-coated endocytic vesicle membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
asymmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
symmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
neuronal cell bodyMuscarinic acetylcholine receptor M2Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M2Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M1Homo sapiens (human)
Schaffer collateral - CA1 synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic density membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M1Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
endoplasmic reticulum membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basal plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basolateral plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (82)

Assay IDTitleYearJournalArticle
AID134595LD50 in mice following i.v. administration.1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates.
AID77620Antimuscarinic activity was assayed for its ability to block the acetyl-choline induced contraction of the guinea pig ileum1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
AID140897Binding affinity for muscarinic acetylcholine receptor M1 by measuring displacement of [3H]QNB from guinea pig cerebral cortex1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
AID1695445Trypanocidal activity against Trypanosoma cruzi Y intracellular amastigote form infected in monkey LLC-MK2 cells2020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID1695446Cytotoxicity against monkey LLC-MK2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID135107Anti-tremorine effect in mice following s.c. administration.1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates.
AID142898Inhibition of (-)-[3H]-QNB muscarinic acetylcholine receptor binding on rat/ dog ventricular muscle1982Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
Analogues of 3-quinuclidinyl benzilate.
AID1148065Toxicity in sc dosed albino mouse assessed as mydriasis measured 120 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID141077Binding affinity for muscarinic acetylcholine receptor M3 by measuring displacement of [3H]QNB from guinea pig parotid gland1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
AID140924In vitro binding affinity against rat heart membrane using [3H]-AF-DX-3841995Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilates.
AID128205Induction of mydriasis in mice following s.c. administration.1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates.
AID1090601Displacement of [3H]QNB from Drosophila melanogaster mAChR by scintillation counting2007Journal of agricultural and food chemistry, Mar-21, Volume: 55, Issue:6
Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
AID16907Biodistribution in rat striatum at 3 hr after dose administration.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID141150Ability of compound to displace (-)-[3H]3-Quinuclidinyl benzilate (-)-[3H]-QNB from Muscarinic acetylcholine receptors in the heart from Guinea Pig.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
AID1148063Toxicity in sc dosed albino mouse assessed as mydriasis measured 30 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID226399Muscarinic receptor binding comparison to QNB, Relative binding index(RBI)1982Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
Analogues of 3-quinuclidinyl benzilate.
AID1148060Anti-tremorine activity against sc dosed albino mouse assessed as normalized dose for reversal of tremorine-induced spontaneous activity depression1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID1695448Selectivity index, ratio of CC50 for human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay to EC50 for Trypanosoma cruzi Y intracellular amastigote form infected in monkey LLC-MK2 cells2020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID141149Ability of compound to displace (-)-[3H]3-Quinuclidinyl benzilate (-)-[3H]-QNB from Muscarinic acetylcholine receptors in cerebral cortex from Guinea Pig.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
AID674902Displacement of [125I]O-iodo-trans-decalinvesamicol from VAChT in Sprague-Dawley rat cerebral membrane after 1 hr by gamma counting2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).
AID1148070Anti-tremorine activity against sc dosed albino mouse assessed as normalized dose for reversal of tremorine-induced spontaneous activity depression measured 120 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID142895Binding affinity constant for muscarinic acetylcholine receptor from rat corpus striatum1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetates.
AID16721Biodistribution in rat cortex at 3 hr after dose administration.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID141140In vitro functional activity in isolated urinary bladder strips from Guinea Pig1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
AID1148062Toxicity in sc dosed albino mouse assessed as mydriasis measured 15 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID157520Inhibition of carbachol-induced release of alpha-amylase from pancreatic acini from rat was determined1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
AID142111Binding affinity for muscarinic acetylcholine receptor M2 by measuring displacement of [3H]QNB from guinea pig heart1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
AID1695449Selectivity index, ratio of CC50 for monkey LLC-MK2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay to EC50 for Trypanosoma cruzi Tulahuen LacZ intracellular amastigote form infected in monkey LLC-MK2 cells incubated for 722020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID140893In vitro binding affinity against bovine striatal membrane using [3H]pirenzepine1995Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilates.
AID141151Ability of compound to displace (-)-[3H]3-Quinuclidinyl benzilate (-)-[3H]-QNB from Muscarinic acetylcholine receptors in the parotid gland from Guinea Pig.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
AID1148061Toxicity in iv dosed mouse1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID16713Biodistribution in rat cerebellum at 3 hr after dose administration.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID79352Antimuscarinic activity was assayed for its ability to block the acetyl-choline induced contraction of the guinea pig ileum1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
AID1695444Trypanocidal activity against Trypanosoma cruzi Tulahuen LacZ intracellular amastigote form infected in monkey LLC-MK2 cells incubated for 72 hrs by chlorophenol red beta-D-galactopyranoside substrate based spectrophotometric assay2020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID20502Relative lipophilicity was determined1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetates.
AID1148064Toxicity in sc dosed albino mouse assessed as mydriasis measured 60 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID1148067Toxicity in sc dosed albino mouse assessed as mydriasis measured 360 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID1148069Anti-tremorine activity against sc dosed albino mouse assessed as normalized dose for reversal of tremorine-induced spontaneous activity depression measured 60 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID141085In vitro binding affinity against guinea pig ileum using [3H]N-methylscopolamine1995Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilates.
AID1148068Anti-tremorine activity against sc dosed albino mouse assessed as normalized dose for reversal of tremorine-induced spontaneous activity depression measured 30 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID16705Biodistribution in rat blood at 3 hr after dose administration.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID141152Affinity for Muscarinic acetylcholine receptors in urinary bladder from Guinea Pig by (-)-[3H]3-Quinuclidinyl benzilate (-)-[3H]-QNB displacement.1997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
AID1695447Cytotoxicity against human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2020RSC medicinal chemistry, Nov-18, Volume: 11, Issue:11
On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.
AID1148059Toxicity in sc dosed albino mouse assessed as mydriasis1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID1090602Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting2007Journal of agricultural and food chemistry, Mar-21, Volume: 55, Issue:6
Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
AID1148071Anti-tremorine activity against sc dosed albino mouse assessed as normalized dose for reversal of tremorine-induced spontaneous activity depression measured 240 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID16728Biodistribution in rat heart at 3 hr after dose administration.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID141156Binding affinity for muscarinic acetylcholine receptor by measuring displacement of [3H]QNB from guinea pig urinary bladder1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
AID1148066Toxicity in sc dosed albino mouse assessed as mydriasis measured 240 mins post medication1977Journal of medicinal chemistry, Dec, Volume: 20, Issue:12
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
AID142896Relative binding index [KA/KA(QNB)] to quiniclidine in muscarinic acetylcholine receptor from rat corpus1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetates.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1987The EMBO journal, Dec-20, Volume: 6, Issue:13
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))1987The EMBO journal, Dec-20, Volume: 6, Issue:13
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))2001Brain research, Oct-05, Volume: 915, Issue:1
Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors.
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))2001Brain research, Oct-05, Volume: 915, Issue:1
Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1987The EMBO journal, Dec-20, Volume: 6, Issue:13
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1987The EMBO journal, Dec-20, Volume: 6, Issue:13
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
AID430616Displacement of [3H]NMS from human muscarinic M1 receptor expressed in CHOK1 cells by microplate scintillation counting2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)ace
AID101556Ability to displace [3H](-)-quinuclidinyl benzilate(QNB) from M2 receptor in rat heart homogenate1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
AID141450Pseudo hill coefficient determined at Muscarinic acetylcholine receptor M11988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID104018Ability to displace [3H]pirenzepine (PZ) from M1 receptor in rat cortex homogenate1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
AID142935Binding affinity against Muscarinic acetylcholine receptor M2 by displacement of [3H]QNB in rat myocardium1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID196390Evaluated for the phosphatidyl inositol turnover at Muscarinic acetylcholine receptor M1 in rat cortex1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID231933Ratio for Ki for M2 (inhibition of adenylate cyclase of rat heart) to Ki for M1 (phosphatidyl inositol turnover in rat cortex)1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID231529Ratio of binding affinity towards M2 (bovine striatum) to M1 (rat myocardium) receptor1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID141695In vitro binding affinity towards Muscarinic acetylcholine receptor M1 using [3H]QNB as radioligand from rat heart tissue1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID142796Pseudo hill coefficient determined at Muscarinic acetylcholine receptor M21988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID34453Evaluated for the inhibition of adenylate cyclase at M2 receptor in rat heart1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID430629Toxicity in Swiss mouse assessed as neurobiological state and occurrence of xerostomia at 30 mg/kg, ip up to 24 hrs2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)ace
AID101728Ability to displace [3H]N-methylscopolamine (NMS) from M3 receptor in rat submaxillary gland homogenate1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
AID142010In vitro binding affinity towards Muscarinic acetylcholine receptor M4 using [3H]QNB as radioligand from rat heart tissue1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID142921Binding affinity against Muscarinic acetylcholine receptor M1 by displacement of [3H]pirenzepine in bovine striatum1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
AID142950Displacement of [3H](-)-quinuclidinyl benzilate(QNB) from muscarinic (M2) receptor in rat heart homogenates1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Muscarinic receptor binding profile of para-substituted caramiphen analogues.
AID233598Ratio of Ki (M1 receptor) to Ki (M2 receptor) was determined1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Muscarinic receptor binding profile of para-substituted caramiphen analogues.
AID142932In vitro binding affinity towards Muscarinic acetylcholine receptor M2 using [3H]-QNB as radioligand from rat heart tissue1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
AID141829Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Muscarinic receptor binding profile of para-substituted caramiphen analogues.
AID430617Displacement of [3H]NMS from human muscarinic M2 receptor expressed in CHOK1 cells by microplate scintillation counting2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)ace
AID430618Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)ace
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (28.57)18.7374
1990's7 (33.33)18.2507
2000's3 (14.29)29.6817
2010's2 (9.52)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.72 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index82.79 (26.88)
Search Engine Supply Index1.99 (0.95)

This Compound (54.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]